FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a medicinal agent for the treatment of urogenital diseases of the human body caused by microorganisms of the species Mycoplasma hominis. Medicine for the treatment of urogenital diseases of the human body caused by microorganisms of the species Mycoplasma hominis, which is a coniferous chlorophyll-carotene complex derived from pine needles based on Pinus Sylvestris and Picea abies (L.) Karst; pharmaceutical composition for the treatment of urogenital diseases of the human body caused by microorganisms of the species Mycoplasma hominis; the use of coniferous chlorophyll-carotene complex for the treatment of urogenital diseases of the human body caused by microorganisms of the species Mycoplasma hominis; a method of treating urogenital diseases of the human body caused by microorganisms of the species Mycoplasma hominis are proposed.
EFFECT: above remedy is effective for the treatment of urogenital diseases of the human body caused by microorganisms of the species Mycoplasma hominis.
5 cl, 7 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINE, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING UROGENITAL DISEASES OF THE HUMAN BODY CAUSED BY MICROORGANISMS OF THE UREAPLASMA UREALYTICUM TYPE | 2017 |
|
RU2677686C1 |
| MEDICINAL AGENT, PHARMACEUTICAL COMPOSITION, HELICOBACTER PYLORI GROWTH INHIBITOR AND METHOD OF ANTIHELICOBACTERY THERAPY | 2007 |
|
RU2367458C1 |
| MEDICINAL AGENT ANTIPROTOZOAL WITH RESPECT TO TRICHOMONAS VAGINALIS IN MODEL SYSTEM IN VITRO | 2008 |
|
RU2366442C1 |
| VIRUCIDAL, BACTERICIDAL, FUNGICIDE AGENT | 2000 |
|
RU2196596C2 |
| KIT FOR LABORATORY DIAGNOSIS OF INFECTIONS CAUSED BY MYCOPLASMA HOMINIS AND UREAPLASMA UREALYTICUM | 2014 |
|
RU2553548C1 |
| RECOMBINANT PSEUDO ADENOVIRAL PARTICLE PRODUCING MODIFIED NANOANTIBODIES RECOGNISING MYCOPLASM MHOMINIS, BASED PHARMACEUTICAL COMPOSITION AND METHOD FOR USING IT FOR MYCOPLASMOSIS THERAPY | 2013 |
|
RU2562158C2 |
| METHOD OF DIFFERENTIATING BACTERIA STRAINS ACCORDING TO RIBOSOMAL RNA GENE | 2008 |
|
RU2386695C1 |
| ACTIVE DRUG INGREDIENT, DRUG, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF DEMYELINATING DISEASES OF LIVING ORGANISM, INCLUDING DISEASE PREVENTION | 2015 |
|
RU2631887C2 |
| METHOD OF DIFFERENTIATING Mycoplasma hominis BACTERIA STRAINS ACCORDING TO RIBOSOMAL RNA GENE | 2008 |
|
RU2386699C2 |
| MONOAMINOOXIDASE INHIBITORS, THERAPEUTIC AGENT AND PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2366430C2 |
